Al-Shayeb, Basem
Sachdeva, Rohan
Chen, Lin-Xing
Ward, Fred
Munk, Patrick
Devoto, Audra
Castelle, Cindy J.
Olm, Matthew R.
Bouma-Gregson, Keith
Amano, Yuki
He, Christine
Méheust, Raphaël
Brooks, Brandon
Thomas, Alex
Lavy, Adi
Matheus-Carnevali, Paula
Sun, Christine
Goltsman, Daniela S. A.
Borton, Mikayla A.
Sharrar, Allison
Jaffe, Alexander L.
Nelson, Tara C.
Kantor, Rose
Keren, Ray
Lane, Katherine R.
Farag, Ibrahim F.
Lei, Shufei
Finstad, Kari
Amundson, Ronald
Anantharaman, Karthik
Zhou, Jinglie
Probst, Alexander J.
Power, Mary E.
Tringe, Susannah G.
Li, Wen-Jun
Wrighton, Kelly
Harrison, Sue
Morowitz, Michael
Relman, David A.
Doudna, Jennifer A.
Lehours, Anne-Catherine
Warren, Lesley
Cate, Jamie H. D.
Santini, Joanne M.
Banfield, Jillian F.
Article History
Received: 22 March 2019
Accepted: 2 January 2020
First Online: 12 February 2020
Competing interests
: The Regents of the University of California have patents pending for CRISPR technologies on which the authors are inventors. J.A.D. is a co-founder of Caribou Biosciences, Editas Medicine, Intellia Therapeutics, Scribe Therapeutics and Mammoth Biosciences, a scientific advisory board member of Caribous Biosciences, Intellia Therapeutics, eFFECTOR Therapeutics, Scribe Therapeutics, Synthego, Mammoth Biosciences and Inari, and is a Director at Johnson & Johnson and has sponsored research projects by Biogen and Pfizer. J.F.B. is a founder of Metagenomi.